AI assistant
ARCONTECH GROUP PLC — Director's Dealing 2019
Mar 29, 2019
7493_dirs_2019-03-29_a8510264-2f05-4b56-bef7-7b2a689c9059.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 5346U
Arcontech Group PLC
29 March 2019
ARCONTECH GROUP PLC
("Arcontech", the "Company" or the "Group")
Director / PDMR Shareholding
Arcontech (AIM: ARC), the provider of products and services for real-time financial market data processing and trading, announces that it has been informed of the following dealings in its ordinary shares of £0.125 each in the Company ("Ordinary Shares") by Matthew Jeffs, Chief Executive of the Company, and persons closely associated (PCA's) with him:
- on 28 March 2019, the sale of 9,109 Ordinary Shares at 121 pence per Ordinary Share by an account in his own name
- on 28 March 2019, the purchase of 9,052 Ordinary Shares at 121.5 pence per Ordinary Share by his ISA
- on 28 March 2019, the purchase of 6,970 Ordinary Shares at 129 pence per Ordinary Share by his ISA
- on 28 March 2019, the in specie transfer of 15,000 Ordinary Shares from an account in his own name to his wife, Suzanne Jeffs
- on 28 March 2019, the sale of 15,000 Ordinary Shares at 121 pence per Ordinary Share by Suzanne Jeffs in her own name
- on 28 March 2019, the purchase of 14,957 Ordinary Shares at 121.2 pence per Ordinary Share by Suzanne Jeffs' ISA
- on 29 March 2019, the purchase of 100 Ordinary Shares at 128.45 pence per Ordinary Share for an account in his own name
- on 29 March 2019, the purchase of 13,030 Ordinary Shares at 128 pence per Ordinary Share by his daughter, Victoria Jeffs in her ISA
Following these transactions, the total beneficial shareholding of Matthew Jeffs and his PCA's has increased to 910,000 Ordinary Shares, representing approximately 6.9% of the Company's issued share capital.
Enquiries:
| Arcontech Group plc | 020 7256 2300 |
| Richard Last, Chairman and Non-Executive Director | |
| Matthew Jeffs, Chief Executive | |
| finnCap Ltd (Nomad & Broker) | 020 7220 0500 |
| Carl Holmes/Simon Hicks | |
To access more information on the Group please visit: www.arcontech.com
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Matthew Jeffs (Chief Executive)
Suzanne Jeffs (PCA)
Victoria Jeffs (PCA)
2.
Reason for the Notification
a)
Position/status
See 1(a) above
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Arcontech Group Plc
b)
LEI
213800O7PM9V79TP7523
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Ordinary shares of £0.125
Identification code
ARC GB00BDBBJZ03
b)
Nature of the transaction
Purchases of Ordinary Shares
Sales of Ordinary Shares
Transfer of Ordinary Shares
c)
Price(s) and volume(s)
| Transaction(s) | Price(s) | Volume(s) | Dates(s) |
| Sale | 121p | 9,109 | 28/03/2019 |
| Purchase | 121.5p | 9,052 | 28/03/2019 |
| Purchase | 129p | 6,970 | 28/03/2019 |
| Transfer | n/a | 15,000 | 28/03/2019 |
| Sale | 121p | 15,000 | 28/03/2019 |
| Purchase | 121.2p | 14,957 | 28/03/2019 |
| Purchase | 128.45p | 100 | 29/03/2019 |
| Purchase | 13,030 | 128 | 29/03/2019 |
d)
Aggregated information:
· Aggregated volume
· Price
See 4 (c) above
e)
Date of the transaction
See 4 (c)
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHZKLFLKXFLBBZ